Automated immunoanalyzer system for performing diagnostic assays for allergies and autoimmune diseases
US10732111B2 · kind B2 · utility
Assignee
Inventors
- Mark David Van Cleve
- Taylor Addison Reid
- Linda Marie Trondle
- Victoria Hung
- Yi Luo
- Dennis Edwin Rieger
- Evan Phillip McMenamy
- Nanditha Raghavan
- Morkoah Blay Reliford
- Douglas John Canfield
- Elaine Grace Taine
- Edsel Lawrence Noche Sinson
- Scott William Vande Wetering
- Teri Taylor
- Travis Knox
- Fran Zylo Cuaresma Jacalne
- James Weston
- Jennifer Bao-Guey Chan
- Stephanie TuVi Ortega
- Rachel Sarah Schell
- Ronald Norman Diamond
- Steve Michael Gann
- Eric Darnell Hall
- Tae Ho Hwang
- John Lewis Morton
- Anatoly Moskalev
- Marinela Gombosev Stack
- Bruce Alan Sargeant
- Michelle Fredrika Forshager
- Vanessa Camille Chua
Key dates
| Filing date | Apr 7, 2017 |
| Grant date | Aug 4, 2020 |
| Priority date | — |
| Expiry date | Oct 16, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/119163
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A quantitative method for performing an automated diagnostic assay, comprising: incubating a capture reagent with a streptavidin-coated medium to form a solid phase complex; washing the solid phase complex to remove excess capture reagent; incubating the solid phase complex with a serum sample to form an immune complex; washing the immune complex to remove any unbound sample; incubating the immune complex with a conjugate to create an immune-conjugate complex; washing the immune-conjugate complex to remove any unbound conjugate; introducing a substrate capable of generating a quantifiable response; and calibrating the response generated from introducing the substrate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.